Implications for the future of the HIV epidemic if drug resistance against dolutegravir cannot occur in first-line therapy

Detalles Bibliográficos
Autores principales: Wainberg, Mark A, Mesplede, Thibault
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International AIDS Society 2015
Materias:
Viewpoint
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671285/
https://www.ncbi.nlm.nih.gov/pubmed/26642452
http://dx.doi.org/10.7448/IAS.18.1.20824
_version_ 1782404383835684864
author Wainberg, Mark A
Mesplede, Thibault
author_facet Wainberg, Mark A
Mesplede, Thibault
author_sort Wainberg, Mark A
collection PubMed
description
format Online
Article
Text
id pubmed-4671285
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher International AIDS Society
record_format MEDLINE/PubMed
spelling pubmed-46712852015-12-07 Implications for the future of the HIV epidemic if drug resistance against dolutegravir cannot occur in first-line therapy Wainberg, Mark A Mesplede, Thibault J Int AIDS Soc Viewpoint International AIDS Society 2015-12-04 /pmc/articles/PMC4671285/ /pubmed/26642452 http://dx.doi.org/10.7448/IAS.18.1.20824 Text en © 2015 Wainberg MA and Mesplede T; licensee International AIDS Society http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Viewpoint
Wainberg, Mark A
Mesplede, Thibault
Implications for the future of the HIV epidemic if drug resistance against dolutegravir cannot occur in first-line therapy
title Implications for the future of the HIV epidemic if drug resistance against dolutegravir cannot occur in first-line therapy
title_full Implications for the future of the HIV epidemic if drug resistance against dolutegravir cannot occur in first-line therapy
title_fullStr Implications for the future of the HIV epidemic if drug resistance against dolutegravir cannot occur in first-line therapy
title_full_unstemmed Implications for the future of the HIV epidemic if drug resistance against dolutegravir cannot occur in first-line therapy
title_short Implications for the future of the HIV epidemic if drug resistance against dolutegravir cannot occur in first-line therapy
title_sort implications for the future of the hiv epidemic if drug resistance against dolutegravir cannot occur in first-line therapy
topic Viewpoint
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671285/
https://www.ncbi.nlm.nih.gov/pubmed/26642452
http://dx.doi.org/10.7448/IAS.18.1.20824
work_keys_str_mv AT wainbergmarka implicationsforthefutureofthehivepidemicifdrugresistanceagainstdolutegravircannotoccurinfirstlinetherapy
AT mespledethibault implicationsforthefutureofthehivepidemicifdrugresistanceagainstdolutegravircannotoccurinfirstlinetherapy

Ejemplares similares